Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB 1 receptors

154Citations
Citations of this article
146Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The α-hemoglobin-derived peptide RVDPVNFKLLSH was found to interact with cannabinoid CB1 receptors. Results: We generated mAbs against RVDPVNFKLLSH and identified a new family of endogenous peptides (Pepcans) that act as negative allosteric modulators at CB1 receptors. Conclusion: Allosteric ligands for CB1 receptors are present in the brain. Significance: Pepcans are a novel class of endogenous modulators of endocannabinoid signaling. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Bauer, M., Chicca, A., Tamborrini, M., Eisen, D., Lerner, R., Lutz, B., … Gertsch, J. (2012). Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB 1 receptors. Journal of Biological Chemistry, 287(44), 36944–36967. https://doi.org/10.1074/jbc.M112.382481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free